Group 1 - The core viewpoint of the article highlights that Sinochem Fertilizer (00297) experienced a decline of over 6% post-earnings announcement, with a current drop of 4.23% to HKD 1.35, and a trading volume of HKD 113 million [1] - Sinochem Fertilizer reported a mid-year revenue of RMB 14.715 billion, representing a year-on-year growth of 7.56%, and a net profit attributable to shareholders of RMB 1.104 billion, up 5.04% year-on-year [1] - The increase in revenue is attributed to growth in both sales volume and average selling prices [1] Group 2 - Changjiang Securities noted that Sinochem Fertilizer is a leading enterprise in China's fertilizer industry, with excellent asset quality, strong profitability, and robust cash flow, maintaining a high dividend payout ratio [1] - The company is expected to maintain a solid position in potassium fertilizer imports, with stable earnings from its core business; the "Bio+" strategy is anticipated to continue driving performance upward [1] - Forecasted net profits attributable to ordinary shareholders for 2025-2027 are RMB 1.46 billion, RMB 1.55 billion, and RMB 1.63 billion, respectively, with an initial coverage rating of "Buy" [1]

Core Viewpoint - Sinochem Fertilizer (00297) experienced a decline of over 6% post-earnings announcement, with a current drop of 4.23% to HKD 1.35, and a trading volume of HKD 113 million [1] Financial Performance - The company reported a revenue of RMB 14.715 billion, representing a year-on-year increase of 7.56% [1] - Shareholder profit attributable to the company was RMB 1.104 billion, up 5.04% year-on-year [1] - Basic earnings per share were RMB 0.1572, with no interim dividend declared [1] Growth Drivers - Revenue growth was primarily driven by an increase in sales volume and average selling prices [1] Industry Position and Future Outlook - Changjiang Securities highlighted that Sinochem Fertilizer is a leading player in China's fertilizer industry, with excellent asset quality, strong profitability, and robust cash flow [1] - The company maintains a high dividend payout ratio, and its position as a key importer of potash fertilizer is expected to remain stable [1] - The "Bio+" strategy is anticipated to continue driving performance upward [1] - Forecasted net profit attributable to ordinary shareholders for 2025-2027 is RMB 1.46 billion, RMB 1.55 billion, and RMB 1.63 billion respectively, with an initial coverage rating of "Buy" [1]

本文源自：金融界 作者：行情君 截至2024年年报，中化化肥营业总收入212.65亿元、净利润10.61亿元。 8月25日，中化化肥披露2025财年中报。 8月25日，中化化肥(00297)盘中下跌5.63%，截至13:03，报1.34元/股，成交5628.63万元。 中化化肥控股有限公司主要业务涵盖化肥资源、研发、生产、分销和农化服务全产业链，是中国化肥行 业首家在香港上市的企业，同时也是中国进口化肥的主渠道。公司拥有逾60年的化肥国际贸易经验，覆 盖了中国95%的耕地面积，磷矿资源位列国内前十，具有最齐全的大量元素、中微量元素肥料以及专用 肥、缓控释肥、生物肥等新型肥料的研发、生产能力。 ...

中化化肥(00297)公布2025年中期业绩，实现营业额人民币147.15亿元，同比增长7.56%;公司股东应占溢 利人民币11.04亿元，同比增长5.04%;每股基本盈利人民币0.1572元。 公告称，营业额增长主要系销量与平均销售价格增长所致。 2025年上半年，该集团依托"耕地保护国家工程研究中心"等国家级研发平台，重点推进"生物+"研发能 力建设及产品创新。在"生物+"研发能力建设方面，新建立1套生物技术研究模型，提升靶向技术研究能 力;搭建"生物+"生测体系，规范"生物+"系列产品田间和盆栽测试评价流程。在技术研究攻关方面，生 物解磷、靶向增效等3项核心生物技术达到应用阶段，并启动相关产品开发。在产品开发转化方面，集 成生物技术，发佈并上市生物肥"智养"、"焕丰"，开发水溶"美麟美"及"蓝麟"升级产品并试产试销，科 研成果转化量达到101万吨，其中高端类产品转化量同比增长59%。 ...

公告称，营业额增长主要系销量与平均销售价格增长所致。 2025年上半年，该集团依托"耕地保护国家工程研究中心"等国家级研发平台，重点推进"生物+"研发能 力建设及产品创新。在"生物+"研发能力建设方面，新建立1套生物技术研究模型，提升靶向技术研究能 力;搭建"生物+"生测体系，规范"生物+"系列产品田间和盆栽测试评价流程。在技术研究攻关方面，生 物解磷、靶向增效等3项核心生物技术达到应用阶段，并启动相关产品开发。在产品开发转化方面，集 成生物技术，发佈并上市生物肥"智养"、"焕丰"，开发水溶"美麟美"及"蓝麟"升级产品并试产试销，科 研成果转化量达到101万吨，其中高端类产品转化量同比增长59%。 智通财经APP讯，中化化肥(00297)公布2025年中期业绩，实现营业额人民币147.15亿元，同比增长 7.56%;公司股东应占溢利人民币11.04亿元，同比增长5.04%;每股基本盈利人民币0.1572元。 ...

Core Viewpoint - Zhonghua Fertilizer (00297.HK) reported a mid-year performance for the first half of 2025, showing a steady growth in revenue and profit, driven by technological innovation and integrated operations [1] Financial Performance - The group's revenue reached RMB 14.715 billion, representing a year-on-year increase of 7.56% [1] - The profit attributable to shareholders was RMB 1.104 billion, reflecting a year-on-year growth of 5.04% [1] - Basic earnings per share were RMB 0.1572, with no dividend declared [1] Strategic Initiatives - The company emphasizes technological innovation as a key driver, leveraging an integrated research, production, and sales operation system [1] - Digital marketing strategies are being utilized to enhance market reach and precision [1] - The implementation of the "Bio+" strategy aims to improve quality and efficiency, addressing both internal and external challenges [1] Profitability Metrics - The net profit margin, calculated as profit attributable to shareholders divided by revenue, stood at 7.5%, remaining stable compared to the same period last year [1]

中化化肥(00297)发布公告，张光艳女士(张女士)已获委任为本公司非执行董事，并将同时担任董事会审 核委员会成员，自2025年8月25日起生效。 ...

智通财经APP讯，中化化肥(00297)发布公告，张光艳女士(张女士)已获委任为本公司非执行董事，并将 同时担任董事会审核委员会成员，自2025年8月25日起生效。 ...

格隆汇8月25日丨中化化肥(00297.HK)宣布，张光艳已获委任为公司非执行董事，并将同时担任董事会 审核委员会成员，自2025年8月25日起生效。 ...

截至二零二五年六月三十日止六個月 財務摘要 1 （於百慕達註冊成立之有限公司） （股份代號：297） 中期業績公告 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其準確性或完 整性亦不發表任何聲明，並明確表示概不會就因本公告全部或任何部份內容而產生或因倚賴該等內 容而引致之任何損失承擔任何責任。 SINOFERT HOLDINGS LIMITED 中化化肥控股有限公司 本集團始終牢記助力糧食安全、服務中國農民的使命責任，聚焦主責主業，堅定推進「生物+」戰略， 以科技創新為核心驅動，強化產業協同和加速商業轉化，提升渠道數字化能力，進一步提質增效， 經營效益及經營效率取得雙增長。 財務業績 截至二零二五年六月三十日止六個月，本集團實現營業額人民幣147.15億元，本公司股東應佔溢利 人民幣11.04億元，同比增長5.04%。 2 研究開發 ‧ 本期本集團營業額人民幣147.15億元，同比增長7.56% ‧ 本期本公司股東應佔溢利人民幣11.04億元，同比增長5.04% ‧ 本期每股基本盈利人民幣0.1572元，同比增長5.04% ‧ 董事會建議不宣派截至二零二五年六月三十日止六個月的中 ...